Prevalence and clinical relevance of systematically tested antimitochondrial antibodies in systemic sclerosis

Immuno-based profiling of knee osteoarthritis patients identifies baseline characteristics associated with positive response to autologous platelet-rich plasma injection at one-year follow-up.

Frontiers in immunology·2026

Macrophage activation syndrome in systemic lupus erythematosus and Still's disease: distinct phenotypes shaped by the underlying diseases.

Rheumatology (Oxford, England)·2026

The placebo effect in psoriatic arthritis.

Autoimmunity reviews·2026

Cancer in Systemic Sclerosis: Clinical Associations and Prognostic Impact From the EUSTAR Registry.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Minimal residual disease flow cytometry of peripheral blood B-cell subsets in patients with idiopathic inflammatory myopathies following rituximab therapy: a single-centre, retrospective cohort study.

The Lancet. Rheumatology·2026

High-sensitivity flow cytometry in rheumatoid arthritis shows that early B-cell subset depletion is linked to 5-year rituximab response, while failure to deplete B cells occurs early in subsequent poly-refractory disease.

Annals of the rheumatic diseases·2026

Differential regulation of SOCS signalling and immunoproteasome pathways by JAK inhibitors and TNF inhibitors in rheumatoid arthritis.

Arthritis research & therapy·2026

Macrovascular damage in polymyalgia rheumatica: integrated vascular phenotyping in the POLYMYACARD cohort.

Arthritis research & therapy·2026

Allogeneic CD19 CAR-NK cell therapy for a patient with relapsed and refractory lupus nephritis.

Arthritis research & therapy·2026

Elevated pro-BNP and low-grade inflammation are associated with low bone mineral density in systemic sclerosis, a case control study.

Arthritis research & therapy·2026

Early risk stratification in lupus nephritis based on established prognostic factors: association with outcomes under triple therapy.

Arthritis research & therapy·2026

Inflammation-driven bone erosion and reactive remodeling in experimental arthritis revealed by cortical bone surface analysis.

Arthritis research & therapy·2026

Real-World Analysis of Switching Between Ranibizumab Biosimilars: Safety and Results - a Multicenter Retrospective Observational Study.

Clinical ophthalmology (Auckland, N.Z.)·2026

Infectious Acute Pancreatitis: Salmonella Typhimurium.

Cureus·2026

The Relationship Between Lichen Planus and Thyroid Disorders in an Iranian Population: A Case-Control Study.

Health science reports·2026

Intravascular Large B-Cell Lymphoma Presenting as Recurrent Cryptogenic Strokes: A Diagnostic Challenge.

Case reports in hematology·2026

Autosomal dominant gain-of-function mutations in LCP1 cause a syndromic neutropenia and immunodeficiency.

Genes & diseases·2026

Fulminant Amyloid-β-Related Angiitis after Tenecteplase: A Biopsy-Confirmed Cause of Post-Thrombolysis Neurologic Deterioration.

The Neurohospitalist·2026

Related Experiment Videos

Prevalence and clinical relevance of systematically tested antimitochondrial antibodies in systemic sclerosis

Related Concept Videos

Immuno-based profiling of knee osteoarthritis patients identifies baseline characteristics associated with positive response to autologous platelet-rich plasma injection at one-year follow-up.

Macrophage activation syndrome in systemic lupus erythematosus and Still's disease: distinct phenotypes shaped by the underlying diseases.

The placebo effect in psoriatic arthritis.

Cancer in Systemic Sclerosis: Clinical Associations and Prognostic Impact From the EUSTAR Registry.

Minimal residual disease flow cytometry of peripheral blood B-cell subsets in patients with idiopathic inflammatory myopathies following rituximab therapy: a single-centre, retrospective cohort study.

High-sensitivity flow cytometry in rheumatoid arthritis shows that early B-cell subset depletion is linked to 5-year rituximab response, while failure to deplete B cells occurs early in subsequent poly-refractory disease.

Differential regulation of SOCS signalling and immunoproteasome pathways by JAK inhibitors and TNF inhibitors in rheumatoid arthritis.

Macrovascular damage in polymyalgia rheumatica: integrated vascular phenotyping in the POLYMYACARD cohort.

Allogeneic CD19 CAR-NK cell therapy for a patient with relapsed and refractory lupus nephritis.

Elevated pro-BNP and low-grade inflammation are associated with low bone mineral density in systemic sclerosis, a case control study.

Early risk stratification in lupus nephritis based on established prognostic factors: association with outcomes under triple therapy.

Inflammation-driven bone erosion and reactive remodeling in experimental arthritis revealed by cortical bone surface analysis.

Real-World Analysis of Switching Between Ranibizumab Biosimilars: Safety and Results - a Multicenter Retrospective Observational Study.

Infectious Acute Pancreatitis: Salmonella Typhimurium.

The Relationship Between Lichen Planus and Thyroid Disorders in an Iranian Population: A Case-Control Study.

Intravascular Large B-Cell Lymphoma Presenting as Recurrent Cryptogenic Strokes: A Diagnostic Challenge.

Autosomal dominant gain-of-function mutations in LCP1 cause a syndromic neutropenia and immunodeficiency.

Fulminant Amyloid-β-Related Angiitis after Tenecteplase: A Biopsy-Confirmed Cause of Post-Thrombolysis Neurologic Deterioration.

Related Experiment Videos

Prevalence and clinical relevance of systematically tested antimitochondrial antibodies in systemic sclerosis

Related Concept Videos

Related Articles